The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis

Nissen, Michael John; Ciurea, Adrian; Bernhard, Jürg; Tamborrini, Giorgio; Mueller, Ruediger; Weiss, Bettina; Toniolo, Martin; Exer, Pascale; Gabay, Cem; Finckh, Axel

doi:10.1002/art.39691

Scientific article

English

The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis

ContributorsNissen, Michael John; Ciurea, Adrian; Bernhard, Jürg; Tamborrini, Giorgio; Mueller, Ruediger; Weiss, Bettina; Toniolo, Martin; Exer, Pascale; Gabay, Cem; Finckh, Axel

Published inArthritis & rheumatology, vol. 68, no. 9, p. 2141-2150

Publication date2016

Abstract

To explore the effect of comedication with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) on drug retention and clinical effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (SpA).

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

NISSEN, Michael John et al. The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis. In: Arthritis & rheumatology, 2016, vol. 68, n° 9, p. 2141–2150. doi: 10.1002/art.39691

Article (Published version)

Identifiers

PID : unige:94195
DOI : 10.1002/art.39691
PMID : 27015429

Journal ISSN2326-5191

449views

0downloads

Creation03/20/2017 9:12:00 PM

First validation03/20/2017 9:12:00 PM

Update time03/15/2023 1:40:42 AM

Status update03/15/2023 1:40:42 AM

Last indexation10/31/2024 5:18:27 PM

Archive ouverte UNIGE

The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis

To explore the effect of comedication with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) on drug retention and clinical effectiveness of tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (SpA).

Technical informations